US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 16.070
  • -0.120-0.74%
Close Jan 17 16:00 ET
  • 15.340
  • -0.730-4.54%
Pre 04:26 ET
235.35MMarket Cap-2.42P/E (TTM)

Anika Therapeutics Key Stats

Anika Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 28.125M--
--2024/Q4-- / 29.000M--
Oct 31, 20242024/Q338.753M / 42.083M--
Aug 8, 20242024/Q241.921M / 40.766M--
May 8, 20242024/Q140.523M / 39.143M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 28.125M--
--2024/Q4-- / 29.000M--
Oct 31, 20242024/Q338.753M / 42.083M--
Aug 8, 20242024/Q241.921M / 40.766M--
May 8, 20242024/Q140.523M / 39.143M--

Unlock Free Earnings Estimates

Anika Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data